A union representing health care workers sued Kaiser Permanente's Colorado operations in October 2021, claiming the medical ...

Tim Mok, PharmD, BCPS, BCOP, malignant hematology pharmacy research analyst at Kaiser Permanente, discussed his perspective on the balance between clinical outcomes and cost considerations.

A union representing health care workers sued Kaiser in October 2021 claiming the medical provider was violating its ...

The last round in 2021 valued the healthcare technology firm at $3.2 billion, more than doubling its valuation from $1.3 ...

A decrease in California's sexually transmitted infections (STIs) followed early real-world adoption of doxycycline ...

The new study, which examined the largest cohort of doxyPEP recipients reported globally to date, used pharmacy data to ...

Health tech company Innovaccer secured a $275 million series F funding round to invest in artificial intelligence with the ...

Innovaccer has raised $275 Mn in its Series F funding round from investors like B Capital Group, Banner Health, Danaher ...

Healthcare SaaS firm Innovaccer, domiciled in the US with operations in India, the US, and the Middle East, said it has ...

A new study has found that rates of chlamydia and syphilis plummet among people prescribed doxycycline for sexually transmitted infection prevention in routine clinical care. The study was led by ...